Concepedia

Gladys Telliam

GT

4

Publications

66

Citations

4

H-Index

2012

Active since

Affiliations

Inserm(Current)

Assistance Publique – Hôpitaux de Paris

Bicêtre Hospital

Hôpital Paul-Brousse

Laboratoire d'études sur les monothéismes

Gladys Telliam is an author at Inserm specializing in hematology, stem cells, and immunology.

Top concepts

HealthMedicineHematologyImmunologyStem CellsCell BiologyAutoimmunityPharmacologyTumor BiologyCancer Research

Publications per year

2012–2023

4

Publications

4

Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML)

Melanie Gentil, Patricia Hugues, Christophe Desterke et al. · PLoS ONE · 2018 · 27 citations · Full text

Mixed-phenotype Acute Leukemia, Immunology, Tumor Biology +17

Dynamics of Human Prothymocytes and Xenogeneic Thymopoiesis in Hematopoietic Stem Cell-Engrafted Nonobese Diabetic-SCID/IL-2rγnull Mice

Véronique Parietti, Elisabeth Nelson, Gladys Telliam et al. · The Journal of Immunology · 2012 · 16 citations · Full text

Lymphocyte Development, Immunology, Immune Regulation +26

Modeling Global Genomic Instability in Chronic Myeloid Leukemia (CML) Using Patient-Derived Induced Pluripotent Stem Cells (iPSCs)

Gladys Telliam, Christophe Desterke, Jusuf Imeri et al. · Cancers · 2023 · 12 citations · Full text

Generation of an induced pluripotent stem cell line from a patient with chronic myeloid leukemia (CML) resistant to targeted therapies

Gladys Telliam, Olivier Féraud, Frank Griscelli et al. · Stem Cell Research · 2016 · 11 citations · Full text

Rows per page

1–4 of 4